Status:
UNKNOWN
Pioglitazone, Body Composition,Insulin Sensitivity and Protein Metabolism in ESRD
Lead Sponsor:
Centre Hospitalier Universitaire Vaudois
Conditions:
ESRD
Eligibility:
All Genders
20+ years
Phase:
PHASE4
Brief Summary
Non diabetic patients on renal replacement therapy are prone to changes in body composition with an increase in visceral fat and muscle wasting all favoured by the insulin resistant state. Malnutritio...
Eligibility Criteria
Inclusion
- Non diabetic individuals with ESRD, on hemodialysis or peritoneal dialysis for at least 3 months. Consent form signed -
Exclusion
- No infectious complication 3 months prior to entry in the study.
- \-
Key Trial Info
Start Date :
March 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
16 Patients enrolled
Trial Details
Trial ID
NCT01253928
Start Date
March 1 2007
Last Update
December 6 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Nephrology Service Department of Medicine CHUV
Lausanne, Canton of Vaud, Switzerland, 1011